We are live on ! Find out more
IMUX icon

Immunic

50 hedge funds and large institutions have $31.3M invested in Immunic in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.07%0.06% (-0%)

6% less funds holding

Funds holding: 5350 (-3)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

30% less capital invested

Capital invested by funds: $44.8M → $31.3M (-$13.5M)

38% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 16

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $17K

Holders
50
Holders Change
-3
Holders Change %
-5.66%
% of All Funds
1.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
10
Reduced
16
Closed
15
Calls
Puts
$17K
Net Calls
-$17K
Net Calls Change
-$101K

IMUX Hedge Fund Activity: Q2 2017 in Review

50 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q2 2017, worth a combined $31.3M — down 30% from $44.8M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of IMUX and 12 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 10 added.

The largest buyer was Millennium Management, adding an estimated $1.38M. The largest seller was BlackRock, cutting an estimated $3.26M.

  • 50 institutional investors held Immunic (IMUX) as of Q2 2017, down from 53 in Q1 2017.
  • Funds reported $31.3M of Immunic stock for Q2 2017, down 30% quarter-over-quarter.
  • 12 funds opened new Immunic positions in Q2 2017 and 15 closed out, a net change of -3 holders.
  • The largest Immunic buyer in Q2 2017 was Millennium Management, an estimated $1.38M added.
  • The largest Immunic seller in Q2 2017 was BlackRock, an estimated $3.26M sold.

Based on aggregated 13F filings for Q2 2017.